Comscore has released data that say that 33 million people researched presciption medications on the internet in Q3. That is up 18% from the same quarter last year.
More important for Big Pharma, 31% of people found the web information by way of an online marketing campaign. Twenty percent got to the information using a search engine.
The top treatment categories researched were bipolar illness, depression, cholesterol, insomnia and acid reflux. In other words, right in the Big Pharma’s big revenue drugs sweet spot.
Put "biploar" into Google. No drug marketing on the first results page. The search for ‘insomnia" brings up a couple of drugs.
Did someone tell Pfizer?
Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about.
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
